The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

for GUSTA trial study group; Barbara Rossetti; Roberta Gagliardini; Gaetana Sterrantino; Vincenzo Colangeli; Alessandra Latini; Manuela Colafigli; Francesca Vignale; Stefano Rusconi; Antonio Di Biagio; Giancarlo Orofino; Ivano Mezzaroma; Vincenzo Vullo; Daniela Francisci; Claudio Mastroianni; Michele Trezzi; Benedetta Canovari; Silvia Lamonica; Arturo Ciccullo; Alberto Borghetti; Antonella DʼArminio Monforte; Simona Di Giambenedetto; Andrea De Luca

doi:10.1097/QAI.0000000000001986

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

for GUSTA trial study group, Barbara Rossetti, Roberta Gagliardini, Gaetana Sterrantino, Vincenzo Colangeli, Alessandra Latini, Manuela Colafigli, Francesca Vignale, Stefano Rusconi, Antonio Di Biagio, Giancarlo Orofino, Ivano Mezzaroma, Vincenzo Vullo, Daniela Francisci, Claudio Mastroianni, Michele Trezzi, Benedetta Canovari, Silvia Lamonica, Arturo Ciccullo, Alberto BorghettiAntonella DʼArminio Monforte, Simona Di Giambenedetto, Andrea De Luca

Istituto S. Maria e S. Gallicano

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e17-e21
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	81
Issue number	1
DOIs	https://doi.org/10.1097/QAI.0000000000001986
Publication status	Published - May 1 2019

Access to Document

10.1097/QAI.0000000000001986

Cite this

group, F. GUSTA. T. S., Rossetti, B., Gagliardini, R., Sterrantino, G., Colangeli, V., Latini, A., Colafigli, M., Vignale, F., Rusconi, S., Di Biagio, A., Orofino, G., Mezzaroma, I., Vullo, V., Francisci, D., Mastroianni, C., Trezzi, M., Canovari, B., Lamonica, S., Ciccullo, A., ... De Luca, A. (2019). The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. Journal of Acquired Immune Deficiency Syndromes, 81(1), e17-e21. https://doi.org/10.1097/QAI.0000000000001986

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. / group, for GUSTA trial study; Rossetti, Barbara; Gagliardini, Roberta et al.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 81, No. 1, 01.05.2019, p. e17-e21.

Research output: Contribution to journal › Article › peer-review

group, FGUSTATS, Rossetti, B, Gagliardini, R, Sterrantino, G, Colangeli, V, Latini, A, Colafigli, M, Vignale, F, Rusconi, S, Di Biagio, A, Orofino, G, Mezzaroma, I, Vullo, V, Francisci, D, Mastroianni, C, Trezzi, M, Canovari, B, Lamonica, S, Ciccullo, A, Borghetti, A, DʼArminio Monforte, A, Di Giambenedetto, S & De Luca, A 2019, 'The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study', Journal of Acquired Immune Deficiency Syndromes, vol. 81, no. 1, pp. e17-e21. https://doi.org/10.1097/QAI.0000000000001986

group FGUSTATS, Rossetti B, Gagliardini R, Sterrantino G, Colangeli V, Latini A et al. The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. Journal of Acquired Immune Deficiency Syndromes. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986

@article{c5fbf307e7be459990b0a8e0bbc54d9e,

title = "The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study",

author = "group, {for GUSTA trial study} and Barbara Rossetti and Roberta Gagliardini and Gaetana Sterrantino and Vincenzo Colangeli and Alessandra Latini and Manuela Colafigli and Francesca Vignale and Stefano Rusconi and {Di Biagio}, Antonio and Giancarlo Orofino and Ivano Mezzaroma and Vincenzo Vullo and Daniela Francisci and Claudio Mastroianni and Michele Trezzi and Benedetta Canovari and Silvia Lamonica and Arturo Ciccullo and Alberto Borghetti and {DʼArminio Monforte}, Antonella and {Di Giambenedetto}, Simona and {De Luca}, Andrea",

year = "2019",

month = may,

day = "1",

doi = "10.1097/QAI.0000000000001986",

language = "English",

volume = "81",

pages = "e17--e21",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

AU - group, for GUSTA trial study

AU - Rossetti, Barbara

AU - Gagliardini, Roberta

AU - Sterrantino, Gaetana

AU - Colangeli, Vincenzo

AU - Latini, Alessandra

AU - Colafigli, Manuela

AU - Vignale, Francesca

AU - Rusconi, Stefano

AU - Di Biagio, Antonio

AU - Orofino, Giancarlo

AU - Mezzaroma, Ivano

AU - Vullo, Vincenzo

AU - Francisci, Daniela

AU - Mastroianni, Claudio

AU - Trezzi, Michele

AU - Canovari, Benedetta

AU - Lamonica, Silvia

AU - Ciccullo, Arturo

AU - Borghetti, Alberto

AU - DʼArminio Monforte, Antonella

AU - Di Giambenedetto, Simona

AU - De Luca, Andrea

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1097/QAI.0000000000001986

DO - 10.1097/QAI.0000000000001986

M3 - Article

VL - 81

SP - e17-e21

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -